Company Quick10K Filing
Akoustis Technologies
10-Q 2020-12-31 Filed 2021-02-01
10-Q 2020-09-30 Filed 2020-10-30
10-K 2020-06-30 Filed 2020-08-21
10-Q 2020-03-31 Filed 2020-05-01
10-Q 2019-12-31 Filed 2020-01-31
10-Q 2019-09-30 Filed 2019-11-07
10-K 2019-06-30 Filed 2019-09-13
10-Q 2019-03-31 Filed 2019-05-10
10-Q 2018-12-31 Filed 2019-02-04
10-Q 2018-09-30 Filed 2018-11-05
10-K 2018-06-30 Filed 2018-08-29
S-1 2018-06-25 Public Filing
10-Q 2018-03-31 Filed 2018-05-15
S-1 2018-01-16 Public Filing
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-14
10-K 2017-06-30 Filed 2017-09-20
10-Q 2017-03-31 Filed 2017-05-15
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-K 2016-03-31 Filed 2016-06-29
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-04-30 Filed 2015-06-22
10-Q 2015-01-31 Filed 2015-03-02
10-Q 2014-10-31 Filed 2014-12-09
10-K 2014-07-31 Filed 2014-10-28
10-Q 2014-04-30 Filed 2014-06-09
8-K 2021-02-19 Enter Agreement, Exhibits
8-K 2021-02-01 Exhibits
8-K 2021-01-25 Other Events, Exhibits
8-K 2020-12-04 Other Events, Exhibits
8-K 2020-10-29
8-K 2020-10-29
8-K 2020-08-28
8-K 2020-05-20
8-K 2020-05-08
8-K 2020-04-17
8-K 2019-12-12
8-K 2019-11-04
8-K 2019-10-25
8-K 2019-04-05
8-K 2019-01-17
8-K 2018-11-12
8-K 2018-11-01
8-K 2018-10-24
8-K 2018-10-18
8-K 2018-10-18
8-K 2018-10-01
8-K 2018-07-24
8-K 2018-05-10
8-K 2018-05-10
8-K 2018-02-27

Akoustis Technologies Financials

AKTS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2014-04-302014-07-312014-10-312015-01-312015-03-312015-04-302015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3106568804,3293,4142,4832,7303,0545,0019,4265,44211,6996,47214,8179,07542,08434,63330,15422,611
Accounts Receivable29305299519215319313159285583
Inventory3100044444350797570584810715094107
PP&E719019421321527069579310,54812,90013,14314,18515,23415,93418,62118,93520,426
Assets3106583204,5133,7142,8513,0873,6205,92111,10616,63924,84519,95129,30824,61757,56252,16547,94942,323
Accounts Payable0049150351461,6131,054128139355845315245218
Long-Term Debt6551,73111,46511,86716,95619,10018,21519,270
Liabilities0001713193285696956812,3171,3441,3025,5704,9153,21115,45815,47721,01022,46521,99423,094
Stockholders' Equity9119-194,1853,1452,1562,4061,3034,5779,80411,06919,93016,73913,8509,14036,55129,70025,95519,229
Income Statement ($'000)2014-04-302014-07-312014-10-312015-01-312015-03-312015-04-302015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000309301445284178313323237569543
Cost of Revenue193330308188144370299200336
Gross Profit108115-24-10169-47-62369207
R&D1943223523556537761,1623,0043,4733,0453,7454,4064,5225,5474,7705,079
SG&A12031335256601,4187242,6181,2632,0671,2041,8332,1902,4422,3402,4601,7862,4601,9952,801
Tax000000000000
Net Income-1-20-3-1-440-25-822-1,069-1,071-3,681-2,073-3,396-2,064-4,643-5,540-4,803-6,752-7,308-6,745-9,434-5,761-8,975
Cash Flow ($'000)2014-04-302014-07-312014-10-312015-01-312015-03-312015-04-302015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-0-20-3-1-426-21-576-1,369-507-1,067-1,059-1,905-1,677-5,057-4,351-3,115-4,748-4,861-4,249-5,798
Cash Investing-23-119-16-34-450-110-2,560-1,944-820-1,690-1,065-2,722-396-1,645
Cash Financing927001,220164,2424,2427706,4404813,258-5513,150711331660